threonic acid has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abumaria, N; Chui, D; Huang, X; Li, W; Liu, G; Liu, XG; Liu, Y; Ren, C; Xiong, W; Yu, J; Zhu, Y | 2 |
2 other study(ies) available for threonic acid and Body Weight
| Article | Year |
|---|---|
Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer's disease mouse model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Body Weight; Brain; Butyrates; Cognition Disorders; Disease Models, Animal; Exploratory Behavior; Glutamate Decarboxylase; Humans; Magnesium; Male; Maze Learning; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Mutation; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Peptide Fragments; Presenilin-1; Presynaptic Terminals; Reaction Time; Synapses; Tissue Distribution; Vesicular Acetylcholine Transport Proteins | 2013 |
Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Analysis of Variance; Animals; Aspartic Acid Endopeptidases; Body Weight; Brain; Butyrates; Cognition Disorders; Disease Models, Animal; Down-Regulation; Female; Hippocampus; Humans; Learning; Male; Memory Disorders; Mice, Transgenic; Motor Activity; Plaque, Amyloid; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Synapses; Synaptic Transmission | 2014 |